---
title: "NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025"
ocid: "ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2025-07-29"
---

# NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323.json)

## Summary

NHS England has completed a procurement process for a framework agreement titled "NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025" aimed at supplying pharmaceutical products. The industries involved are pharmaceutical, with a total value of £4,108,145,000. The tender, classified under CPV code 33600000, encompasses areas in the United Kingdom, Channel Islands, and others, with the contract period commencing on 1 September 2025 and ending on 31 August 2027. The procurement stage is currently at the 'Award' phase as of 29 July 2025. The open procedure was above the threshold and was designed to include SMEs in the bidding process. This process also details the framework agreement's flexibility to extend for additional periods, indicating a robust and long-term supply opportunity.

This tender presents a significant opportunity for firms in the pharmaceutical industry to engage with NHS England, a key player and buyer in the healthcare sector. With a focus on both large suppliers and SMEs, the framework agreement provides multiple chances for participation across a broad geographical scope. Companies such as Biogen and Amgen Ltd, which have been successful suppliers, illustrate the competitive landscape. This framework is particularly suitable for businesses providing branded medicines, offering a substantial business growth opportunity through long-term collaboration with a national health service. Active involvement can yield benefits from a stable and assured market for the duration of the contract and potential extensions.

## Notice

NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/cc644418-f584-45db-bf35-771baf03bc48 |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure (above threshold) |
| Tender suitability | SME |
| Awardee scale | Large, SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 29 Jul 2025 |
| Submission deadline | 7 Apr 2025 |
| Future notice date | Not specified |
| Award date | 30 Jun 2025 |
| Contract period | 31 Aug 2025 - 31 Aug 2027 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £4,108,145,000 |
| Lots value | Not specified |
| Awards value | £986,282,758 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 21 |
| Supplier names | ABBVIE; ACCORD-UK; ALEXION PHARMACEUTICALS; AMGEN; BIOGEN; CELLTRION HEALTHCARE UNITED KINGDOM; CURATEQ BIOLOGICS; DR.REDDY'S LABORATORIES (UK; FRESENIUS KABI; GLAXOSMITHKLINE; JANSSEN-CILAG; ORGANON PHARMACEUTICALS; ORIFARM; PFIZER; ROCHE PRODUCTS; SAMSUNG BIOEPIS; SANDOZ; SOBI (SWEDISH ORPHAN BIOVITRUM; TAKEDA; THORNTON AND ROSS; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 29 Jul 2025 at 14:36 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/cc644418-f584-45db-bf35-771baf03bc48

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/cc644418-f584-45db-bf35-771baf03bc48
  29th July 2025 - Awarded contract notice on Contracts Finder
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/51e8b80a-2d92-497b-a1d3-d72fd03b7d66
  Framework Agreement and Terms and Conditions - Tranche B - 1 September 2025
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/bcacc114-9f59-4a94-b39d-4682179cdafc
  Tranche B -Transparency Award Schedules - CM_PHR_24_5680_01
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/024718c4-213a-4a7b-af5c-4787724c059c
  Tranche B -Transparency Award Schedules - CM_PHR_24_5680_02

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323.json.